Mood disorders (e.g. anxiety, depression) are commonly associated with migraine. These should be monitored, and treatment offered as appropriate.[5]Oskoui M, Pringsheim T, Billinghurst L, et al. Practice guideline update summary: pharmacologic treatment for pediatric migraine prevention. Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2019 Sep 10;93(11):500-9.
https://www.neurology.org/doi/10.1212/WNL.0000000000008105
http://www.ncbi.nlm.nih.gov/pubmed/31413170?tool=bestpractice.com
[25]Eigenbrodt AK, Ashina H, Khan S, et al. Diagnosis and management of migraine in ten steps. Nat Rev Neurol. 2021 Aug;17(8):501-14.
https://www.nature.com/articles/s41582-021-00509-5
http://www.ncbi.nlm.nih.gov/pubmed/34145431?tool=bestpractice.com
[66]Hovaguimian A, Roth J. Management of chronic migraine. BMJ. 2022 Oct 10;379:e067670.
http://www.ncbi.nlm.nih.gov/pubmed/36216384?tool=bestpractice.com
However, evidence for a beneficial effect of psychological therapies for improving depression or anxiety in children with headache and other chronic pain conditions is unclear.[67]Fisher E, Law E, Dudeney J, et al. Psychological therapies for the management of chronic and recurrent pain in children and adolescents. Cochrane Database Syst Rev. 2018 Sep 29;(9):CD003968.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003968.pub5/full
http://www.ncbi.nlm.nih.gov/pubmed/30270423?tool=bestpractice.com
[68]Thabrew H, Stasiak K, Hetrick SE, et al. E-Health interventions for anxiety and depression in children and adolescents with long-term physical conditions. Cochrane Database Syst Rev. 2018 Aug 15;(8):CD012489.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012489.pub2/full
http://www.ncbi.nlm.nih.gov/pubmed/30110718?tool=bestpractice.com